Additionally, we showed that the community cohesion scores can be used to predict the drug response and suggested the potential combination therapies (e.g. NADPT or RXRA inhibitors) to reduce tamoxifen resistance for ER+ breast cancer. Here, ESR1 is linked to breast carcinoma.